Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)
Capital Expenditure
-$139.50M
TTM · Period ending: · USD
BIO Capital Expenditure
Latest reported-$139.50Mperiod ending
Latest reported-$139.50Mperiod ending
BIO TTM CapEx (-$13.40M → -$139.50M)
TTM CapEx
High-resolution chart · PNG
BIO capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -34,000,000 | |
| -32,366,000 | |
| -31,406,000 | |
| -234,041,000 | |
| -236,157,000 | |
| -233,818,000 | |
| -230,100,000 | |
| -26,800,000 | |
| -24,000,000 | |
| -21,600,000 | |
| -21,200,000 | |
| -53,100,000 | |
| -53,900,000 | |
| -54,200,000 | |
| -54,800,000 | |
| -21,000,000 | |
| -18,000,000 | |
| -17,400,000 | |
| -15,200,000 | |
| -13,600,000 | |
| -12,600,000 | |
| -12,200,000 | |
| -12,300,000 | |
| -12,600,000 | |
| -12,100,000 | |
| -10,800,000 | |
| -9,800,000 | |
| -9,300,000 | |
| -9,200,000 | |
| -11,900,000 | |
| -14,500,000 | |
| -16,100,000 | |
| -19,800,000 | |
| -20,100,000 | |
| -20,400,000 | |
| -24,000,000 | |
| -25,900,000 | |
| -30,000,000 | |
| -31,000,000 | |
| -27,700,000 | |
| -22,600,000 | |
| -16,800,000 | |
| -13,400,000 | |
| -13,400,000 | |
| -13,800,000 |